The Prognostic Impact of Eosinophils and the Eosinophil-to-Lymphocyte Ratio on Survival Outcomes in Stage II Resectable Pancreatic Cancer-Reference-Cited by-同舟云学术

The Prognostic Impact of Eosinophils and the Eosinophil-to-Lymphocyte Ratio on Survival Outcomes in Stage II Resectable Pancreatic Cancer

Published:2021-02 Issue:2 Volume:50 Page:167-175
ISSN:1536-4828
Container-title:Pancreas
language:en
Short-container-title:Pancreas

Author:

Ohkuma Ryotaro,Kubota Yutaro,Horiike Atsushi,Ishiguro Tomoyuki,Hirasawa Yuya,Ariizumi Hirotsugu,Watanabe Makoto,Onoue Rie,Ando Kiyohiro,Tsurutani Junji,Yoshimura Kiyoshi,Aoki Takeshi,Murakami Masahiko,Kobayashi Shinichi,Tsunoda Takuya,Wada Satoshi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference40 articles.

1. Global cancer statistics;CA Cancer J Clin,2011

2. Cancer statistics, 2018;CA Cancer J Clin,2018

3. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary;Eur J Cancer,2009

4. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Cancer Res,2014

5. Pancreatic cancer;Lancet,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Granulocytes and mast cells in AllergoOncology—Bridging allergy to cancer: An EAACI position paper;Allergy;2024-07-22

2. Associations between eosinophils and cancer risk in the UK Biobank;International Journal of Cancer;2024-05-02

3. ATX restricts anti-tumor eosinophil responses;Nature Cancer;2024-02-28

4. Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Eosinophil-to-Lymphocyte Ratio (ELR) as Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD);International Journal of Chronic Obstructive Pulmonary Disease;2024-02

5. Autotaxin–lysolipid signaling suppresses a CCL11–eosinophil axis to promote pancreatic cancer progression;Nature Cancer;2024-01-09